Moolec Receives Nasdaq Determination Letter: Requests Stay of Suspension

Moolec Science SA, a company that engineers plants and microbes to unlock scalable protein solutions, has received a letter from Nasdaq stating it is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to not filing its Annual Report on Form 20-F for the year ended June 30, 2025. Moolec requested a stay of suspension and expects to file the Form 20-F before the hearing on December 18, 2025. The company's shares will continue to trade on Nasdaq without interruption during the stay.